Armistice Capital »

Entegris shares owned by Armistice Capital

Quarter-by-quarter ownership of Entegris (ENTG) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Entegris

Tip: Access up to 7 years of quarterly data

All positions including Entegris held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entegris by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.0M 17k 179.86

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Entegris

BlackRock
T. Rowe Price Associates
Capital Research Global Investors
Vanguard Portfolio Management
Vanguard Capital Management
Principal Financial Group
Invesco
Jpmorgan Chase & Co
State Street Corporation
PRIMECAP Management Company
Geode Capital Management
Bank of America Corporation
Barrow, Hanley, Mewhinney & Strauss
Select Equity
London Company

View all funds holding Entegris